Multiple Spontaneous Cerebral Microbleeds and Leukoencephalopathy in PSEN1-Associated Familial Alzheimer's Disease: Mirror of Cerebral Amyloid Angiopathy?

Journal of Alzheimer's Disease

Volumn 47, Issue 3, 2015, Pages 535-538

  Floris, Gianluca ^a   Di Stefano, Francesca ^a   Cherchi, Maria Valeria ^a   Costa, Gianna ^a   Marrosu, Francesco ^a   Marrosu, Maria Giovanna ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Alzheimer's disease; amyloid angiopathy; ARIA; cerebral microbleeds; PSEN1 mutation

Indexed keywords

APOLIPOPROTEIN E3; BIOLOGICAL MARKER; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; BRAIN HEMORRHAGE; CASE REPORT; CEREBROSPINAL FLUID; DEMENTIA; GENE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; LEUKOENCEPHALOPATHY; MALE; MULTIPLE SPONTANEOUS CEREBRAL MICROBLEED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSEN1 GENE; RISK FACTOR; SPASTIC PARAPLEGIA; VASCULAR AMYLOIDOSIS; WHITE MATTER; BRAIN; FEMALE; GENETICS; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PEDIGREE; SIBLING;

ALZHEIMER DISEASE; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; PEDIGREE; PRESENILIN-1; SIBLINGS;

EID: 84938675988     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150165     Document Type: Article

References (18)

1. Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ (2011) Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimers Association Research Roundtable Workgroup. Alzheimers Dement 7, 367-385.
2. Ryan NS, Lashley T, Revesz T, Dantu K, Fox NC, Morris HR (2015) SpontaneousARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in Presenilin 1-Associated familial Alzheimers disease. J Alzheimers Dis 44, 1069-1074.
3. Carlson C, Estergard W, Oh J, Suhy J, Jack CR, Siemers E, Barakos J (2011) Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimers disease study cohorts from phase 3 trials of semagacestat and solanezumab. Alzheimers Dement 7, 396-401.
4. Boncoraglio GB, Piazza F, Savoiardo M, Farina L, DiFrancesco JC, Prioni S, Tagliavini F, Parati EA, Giaccone G (2015) Prodromal Alzheimers disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies. J Alzheimers Dis 45, 363-367.
5. Raman MR, Wiste HJ, Senjem ML, Ward CP, Jack CR, Kantarci K (2014) Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult. Neurology 4, 1171-1172.
6. Kim BJ, Lee SH (2013) Cerebral microbleeds: Their associated factors, radiologic findings, and clinical implications. J Stroke 15, 153-163.
7. Saba L, Raz E, Bassareo PP, di Martino M, de Cecco CN, Mercuro G, Grassi R, Suri JS, Piga M (2015) Is there an association between cerebral microbleeds and leukoaraiosis? J Stroke Cerebrovasc Dis 24, 284-289.
8. Saba L, Montisci R, Raz E, Sanfilippo R, Suri JS, Piga M (2012) Association between carotid artery plaque type and cerebral microbleeds. AJNRAmJ Neuroradiol 33, 2144-2150.
9. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, Launer LJ, Van Buchem MA, Breteler MM, Microbleed Study Group (2009) Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol 8, 165-174.
10. Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I, Nitrini R, Sakaguchi H, Brioschi M, Billo G, Colombo A, Lanzani F, Piscosquito G, Carriero MR, Giaccone G, Tagliavini F, Ferrarese C, DiFrancesco JC (2013) Anti-Amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloidmodifying therapies. Ann Neurol 73, 449-458.
11. Ryan NS, Bastos-Leite AJ, Rohrer JD, Werring DJ, Fox NC, Rossor MN, Schott JM (2012) Cerebral microbleeds in familial Alzheimers disease. Brain 135, e201; author reply e202.
12. Marrosu MG, Floris G, Costa G, Schirru L, Spinicci G, Cherchi MV, Mura M, Mascia MG, Cocco E (2006) Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation. Neurology 66, 108-111.
13. Van Rooden S, van der Grond J, van den Boom R, Haan J, Linn J, Greenberg SM, van Buchem MA (2009) Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke 40, 3022-3027.
14. ORiordan S, McMonagle P, Janssen JC, Fox NC, Farrell M, Collinge J, Rossor MN, Hutchinson M (2006) Presenilin-1 mutation (E280G) , spastic paraparesis, and cranial MRI white-matter abnormalities. Neurology 59, 1108-1110.
15. Mann DM, Pickering-Brown SM, Takeuchi A, Iwatsubo T, Members of the Familial Alzheimers Disease Pathology Study Group (2001) Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimers disease. Am J Pathol 158, 2165-2175.
16. Difrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, Galimberti G, Conti E, Curto NA, Marzorati L, Remida P, Tagliavini F, Savoiardo M, Ferrarese C (2011) Anti-Aβ autoantibodies in the CSF of a patient with Caa-related inflammation: A case report. Neurology 76, 842-844.
17. Greenberg SM, Frosch MP (2011) Life imitates art: Antiamyloid antibodies and inflammatory cerebral amyloid angiopathy. Neurology 76, 772-773.
18. Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteins son AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, Gregg KM, Brashear HR, Kinney GG, Black R, Grundman M (2012) Amyloid-related imaging abnormalities in patients with Alzheimers disease treated with bapineuzumab: A retrospective analysis. Lancet Neurol 11, 241-249.